Kallikrein 9 antibody (C-Term) (FITC)

Catalog No. ABIN8003943

The Rabbit Polyclonal anti-Kallikrein 9 antibody is suitable to detect Kallikrein 9 in samples from Human. It has been validated for FACS.

Quick Overview for Kallikrein 9 antibody (C-Term) (FITC) (ABIN8003943)

Target: Kallikrein 9 (KLK9)

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Kallikrein 9 antibody is conjugated to FITC

Application: Flow Cytometry (FACS)

Product Details anti-Kallikrein 9 Antibody (FITC)

Binding Specificity: C-Term

Purpose: Anti-Kallikrein 9/KLK9 Antibody FITC Conjugated

Specificity: No cross reactivity with other proteins.

Cross-Reactivity (Details): No cross-reactivity with other proteins

Purification: Immunogen affinity purified.

Immunogen: A synthetic peptide corresponding to a sequence at the C-terminus of human Kallikrein 9.

Isotype: IgG

Application Details

Application Notes: Flow Cytometry, Optimal dilutions should be determined by end users.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

Expiry Date: 12 months

Target Details for Kallikrein 9

Target: Kallikrein 9 (KLK9)

Alternative Name: KLK9

Background:

Background: KLK9 (kallikrein-related peptidase 9) also known as kallikrein 9 or KLK-L3, belongs to the kallikrein subgroup of serine proteases, which have diverse physiologic functions in many tissues. The KLK9 gene contains 5 coding exons and is mapped to 19q13.41. The KLK9 gene is regulated by steroid hormones in a human breast cancer cell line. Yousef et al. (2001) performed a quantitative analysis of KLK9 expression in ovarian cancer. The results indicated thatKLK9 is under steroid hormone regulation in ovarian and breast cancer cell lines. KLK9 is a potential independent favorable prognostic marker for early-stage, low-grade, optimally debulked ovarian cancer patients.

Gene Full Name: kallikrein related peptidase 9

Sequence Similarities: Belongs to the peptidase S1 family. Kallikrein subfamily.

Gene ID: 284366

UniProt: Q9UKQ9

Pathways: Complement System